I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 6 studies | 21% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 3% | |
| regulatory T cell | 5 studies | 17% ± 1% | |
| plasma cell | 4 studies | 24% ± 5% | |
| natural killer cell | 4 studies | 16% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| myofibroblast cell | 3 studies | 19% ± 3% | |
| abnormal cell | 3 studies | 17% ± 2% | |
| mature NK T cell | 3 studies | 16% ± 1% |
